melobax 15 15 mg tabletki
ranbaxy (poland) sp. z o.o. - meloxicamum - tabletki - 15 mg
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - leki stosowane w leczeniu chorób kości - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
clotrimazolum gsk 10 mg/g krem
gsk psc poland sp. z o.o. - clotrimazolum - krem - 10 mg/g
clotrimazolum gsk 100 mg tabletki dopochwowe
gsk psc poland sp. z o.o. - clotrimazolum - tabletki dopochwowe - 100 mg
clotrimazolum gsk 500 mg tabletki dopochwowe
glaxosmithkline pharmaceuticals s.a. - clotrimazolum - tabletki dopochwowe - 500 mg
diflucan 2 mg/ml roztwór do infuzji
pfizer europe ma eeig - fluconazolum - roztwór do infuzji - 2 mg/ml
polfungicid (50 mg + 10 mg)/ml roztwór na skórę
bausch health ireland ltd. - chlormidazoli hydrochloridum + acidum salicylicum - roztwór na skórę - (50 mg + 10 mg)/ml
zofran 2 mg/ml roztwór do wstrzykiwań
novartis poland sp. z o.o. - ondansetroni hydrochloridum dihydricum - roztwór do wstrzykiwań - 2 mg/ml
zofran 4 mg tabletki powlekane
sandoz gmbh - ondansetroni hydrochloridum dihydricum - tabletki powlekane - 4 mg
zofran 8 mg tabletki powlekane
sandoz gmbh - ondansetroni hydrochloridum dihydricum - tabletki powlekane - 8 mg